Director Dealings
Director dealings: Currys CFO lowers stake
Currys revealed on Friday that chief financial officer Bruce Marsh had disposed of 500,000 ordinary shares in the FTSE 250-listed electrical goods retailer.
Director dealings: British American Tobacco's Karen Guerra purchases shares
British American Tobacco revealed on Thursday that non-executive director Karen Guerra had acquired 6,000 ordinary shares in the FTSE 100-listed tobacco giant.
Director dealings: Convatec non-executive director makes share purchase
Convatec revealed on Wednesday that non-executive director Jens Viebke had acquired 24,400 ordinary shares in the FTSE 100-listed medical products and technology firm.
Director dealings: Mortgage Advice Bureau chairman snaps up shares
Mortgage Advice Bureau revealed on Tuesday that non-executive chairman Michael Jones had acquired 5,833 ordinary shares in the AIM-listed property finance platform operator.
Director dealings: Insig Ai CEO raises stake
Insig Ai revealed on Monday at chief executive Richard Bernstein had acquired 400,000 ordinary shares in the AIM-listed data infrastructure and machine learning firm.
Director dealings: IG Design CFO picks up stake
IG Design Group revealed on Friday that chief financial officer Ari Bensoussan had acquired 465,799 ordinary shares in the AIM-listed stationery firm.
Director dealings: First Property Group CEO raises stake
First Property Group revealed on Wednesday that chief executive Ben Habib had acquired 300,000 shares in the AIM-listed property fund manager.
Director dealings: CMC Markets founder raises stake
CMC Markets revealed on Tuesday that chief executive Peter Crudds had acquired 593,378 ordinary shares in the FTSE 250-listed financial services firm.
Director dealings: James Cropper director raises stake
James Cropper revealed on Monday that non-executive director on Yeung had acquired 7,300 ordinary shares in the London-listed papermaking and advanced materials company.
Director dealings: Symphony International Holdings director continues to buy
A director of Asia-focused investment company Symphony International Holdings continued to ramp up his investment in the company on Friday, purchasing a further $200,000 of shares.
Director dealings: Checkit CEO snaps up shares
Checkit revealed on Thursday that chief executive Kit Kyte had acquired 618,745 ordinary shares in the AIM-listed automated monitoring platform operator.
Director dealings: Sysgroup non-executive director raises stake
Sysgroup revealed on Wednesday that non-executive director Michael Fletcher had acquired 77,623 ordinary shares in the AIM-listed managed technology partner.
Director dealings: Midwich CFO takes up stake
Midwich revealed on Tuesday that chief financial officer Adam Councell had acquired 74,586 ordinary shares in the AIM-listed technology solutions provider.
Director dealings: Sirius Real Estate CEO snaps up shares
Sirius Real Estate revealed on Monday that chief executive Andrew Coombs had acquired 100,000 ordinary shares in the FTSE 250-listed property firm.
Director dealings: Trufin CEO snaps up more shares
Trufin revealed on Friday that chief executive James van den Bergh had acquired 25,000 ordinary shares in the AIM-listed software firm.
Director dealings: Oxford Biomedica chair ups stake
The largest market purchase of shares in London on Thursday came from Oxford Biomedica's chair Roch Doliveux. who upped his stake in the cell and gene therapy company after a sharp drop in the stock over the year to date.
Director dealings: Intercede's Dan O'Brien raises stake
Intercede Group revealed on Wednesday that non-executive director Dan O'Brien had acquired 22,070 ordinary shares in the AIM-listed cybersecurity software firm.
Director dealings: Foreterra non-executive director snaps up shares
Forterra revealed on Tuesday that non-executive director Gavin Hill had acquired 28,944 ordinary shares in the London-listed building products manufacturer.
Director dealings: Trufin CEO raises stake
Trufin revealed on Monday that chief executive James van den Bergh had acquired 150,000 ordinary shares in the AIM-listed software firm.
Director dealings: Astrazeneca CEO raises stake
Astrazeneca revealed on Friday that chief executive Pascal Soriot had acquired 60,000 ordinary shares in the FTSE 100-listed drugmaker.